The CLA phenotype can be stratified by the expression of epithelial lineage gene signatures, e.g., GATA6, and is generally less aggressive and sufficiently responsive to chemotherapy compared with the BL subtype (16, 20, 30, 43). The gene discussed is GATA6; the disease is Burkitt lymphoma.